|
HS Code |
294868 |
| Cas Number | 35737-35-6 |
| Molecular Formula | C10H14O |
| Molecular Weight | 150.22 g/mol |
| Iupac Name | 2,3-dehydrocamphor |
| Synonyms | Dehydrocamphor, 2,3-Dehydrocamphonine |
| Appearance | White to off-white crystalline solid |
| Melting Point | 104-106°C |
| Boiling Point | 212-214°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Pubchem Cid | 21782387 |
| Smiles | CC1(C2CCC(=O)C2(C1)C)C |
| Density | 1.01 g/cm³ |
| Refractive Index | 1.484 |
| Storage Conditions | Store at room temperature, keep container tightly closed |
| Hazard Statements | May cause irritation to skin and eyes |
As an accredited Dehydrocamphonine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Dehydrocamphonine, 25 grams, supplied in a sealed amber glass bottle with tamper-evident cap, labeled with safety and handling information. |
| Shipping | Dehydrocamphonine is shipped in secure, airtight containers to prevent contamination and degradation. Packages are clearly labeled and handled according to chemical safety regulations, often requiring temperature control and protection from light. Material Safety Data Sheets (MSDS) accompany shipments, ensuring compliant, safe transportation and handling throughout the delivery process. |
| Storage | Dehydrocamphonine should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. It should be kept away from sources of ignition, heat, and incompatible substances such as strong oxidizers. Proper labeling is essential, and access should be restricted to trained personnel. Store according to local regulations for chemicals. |
|
Purity 98%: Dehydrocamphonine with Purity 98% is used in pharmaceutical synthesis, where it ensures high reaction efficiency and product yield. Melting Point 45°C: Dehydrocamphonine with Melting Point 45°C is used in topical formulation development, where it provides stable incorporation in thermo-sensitive emulsions. Particle Size <20 µm: Dehydrocamphonine with Particle Size <20 µm is used in fine chemical compounding, where it enhances solubility and uniform dispersion. Stability Temperature 70°C: Dehydrocamphonine with Stability Temperature 70°C is used in industrial processing, where it maintains integrity under elevated processing conditions. Molecular Weight 152.23 g/mol: Dehydrocamphonine with Molecular Weight 152.23 g/mol is used in chiral catalyst systems, where it delivers consistent enantioselectivity during asymmetric synthesis. Viscosity Grade Low: Dehydrocamphonine with Low Viscosity Grade is used in cosmetic formulations, where it enables smooth blending and improved application texture. Water Solubility 5 mg/mL: Dehydrocamphonine with Water Solubility 5 mg/mL is used in injectable drug preparations, where it ensures rapid dissolution and bioavailability. Optical Purity >99% ee: Dehydrocamphonine with Optical Purity >99% ee is used in enantiomeric drug production, where it promotes high stereospecific activity. |
Competitive Dehydrocamphonine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
For chemists, perfumers, and formulators who spend time evaluating each raw material, the difference between routine and well-crafted compounds stands out from the first inspection. Dehydrocamphonine is not a high-profile ingredient that headlines industry award presentations, but over years of producing this compound at scale, we've recognized its quiet significance in essential oil refinement, sophisticated aroma blends, and synthetic intermediates.
As a manufacturer specializing in monoterpenoids and related compounds, we've gotten to know the ins and outs of producing high-purity Dehydrocamphonine. The molecule’s backbone, a bicyclic terpene ketone, presents opportunities and technical hurdles from the start—beginning with raw material selection. Starting from camphor derivatives, our team selects feedstock based on detailed GC analysis and known batch performance. Early on, we saw how the choice of starting material dictated not only the final purity but the subtle aroma profile that matters to niche customers.
We've heard from longtime partners in fine chemicals that “close” is never good enough with fragrance precursors or intermediates for pharmaceuticals. Dehydrocamphonine, when produced with the expected attention, answers that challenge. Our product arrives at minimum 97% purity by GC, as confirmed batch after batch in our in-house and third-party labs. This isn’t simply a sales bullet—it comes from the years of optimization that pushed aside yields in favor of purity and consistency. We settled for a bit less throughput to meet the demands we’ve come to expect from our own output.
Formulators reach for Dehydrocamphonine primarily because of its role in advanced aroma blend design and as an intermediate for certain synthetic programs. Some fine fragrance houses use it in reconstitution of natural camphoraceous notes, while specialty chemical labs use it as a stepping stone for building more complex bicyclic molecules.
We see perfume houses in Europe requesting this material due to its crisp, almost menthol-camphor edge, though not as pronounced as straight camphor. The subtlety allows for depth in blends where a single overpowering note might ruin the effect. In medicinal chemistry, its structure invites further functionalization, with teams pursuing novel derivatives for early-stage screening.
The push toward higher-purity grades for Dehydrocamphonine has become more pronounced over the past five years, likely a result of increasing regulatory scrutiny and tighter downstream process controls. Longstanding clients in pharmaceutical R&D want to avoid secondary purification steps or analytical headaches from trace byproducts. That pressure comes back to us—if an impurity or trace byproduct slips past, it's not just a purity issue, it could change the outcome of an entire research program or violate a tight specification. This sort of feedback drives our internal releases. No product leaves without full batch documentation, with purity results traceable to the analytical run.
Working with camphor and its derivatives for over a decade has shown how subtle changes in structure bring pronounced changes in behavior. Unlike camphor itself, Dehydrocamphonine does not possess the distinct sharpness or volatility, which appeals to those seeking softer, more sophisticated top notes. Nor does it present the medicinal intensity of borneol or isoborneol, making it easier for perfumers to weave it into compositions without concern for medicinal overload.
We’ve met formulators who switched from natural camphor or borneol to Dehydrocamphonine specifically for its balanced finish and reduced sensory fatigue—especially important when building products for daily use like air fresheners or skin-contacted fragrances. For those in the pharma route, the more accessible ketone group offers a gateway to further synthetic elaboration, which can't always be said about the more oxidized or alcohol-based camphor siblings.
If a project asks for high odor persistence, Dehydrocamphonine holds its note better than simple terpenes but isn’t as heavy-handed as synthetic musks. Its intermediate volatility suits it across industries—aroma, fine chemicals, and pharma intermediates—without pushing the boundaries of regulatory lists or workplace safety levels.
We began refining our approach to Dehydrocamphonine after we ran into repeat batch variations from inconsistent reaction kinetics. The solution meant going beyond textbook conditions. Several rounds of pilot work honed our protocols, especially managing byproduct formation in the dehydration step. For us, the real learning curve traced to scaling—lab success rarely transitioned smoothly to full tonnage. With high-shear mixing and in-line analysis, we finally stabilized product quality.
More than one client has approached us seeking “just a little” Dehydrocamphonine for screening, only to return later needing multi-kilo orders. These transitions put strain on procurement, yet our own close management of sourcing and batch scheduling makes fulfillment possible. Holding the reins on both raw material purification and core reaction means we can make meaningful improvements quickly, without bureaucratic delays.
Handling a compound with camphor lineage brings the responsibility of odor containment and air purity. Our team addressed this by upgrading vapor management in critical zones and ensuring finished material posts minimal off-gassing, as confirmed by headspace analysis. Accidents from lower-tier suppliers in the past have reminded the industry that the entire upstream and downstream process matters—not just the final shipment.
Feedback from formulators reveals that Dehydrocamphonine’s lightweight character proves valuable in blends aiming for subtlety. A niche French fragrance house once commented that Dehydrocamphonine “fell in line” with their green-herbal bases, lifting top notes without overwhelming the floral heart. The measured purity and lack of unreacted camphor scored points for clarity and predictability in finished products.
Industrial users, on the other hand, have told us that downstream handling of our Dehydrocamphonine requires little-to-no additional rework, saving days in the lab. Years ago, storage conditions rattled us—terpenoids in bulk sometimes succumb to oxidation or odor loss, but tweaking packaging and nitrogen capping eliminated those calls from warehouse managers. Even in humid conditions, product stability remained robust—a real lesson in the practical value of end-to-end attention by those making the compound.
Some smaller volume customers in pharma development need technical flexibility—requests for specialized grades, micro-filtration, or custom lot splitting. Since we oversee the entire manufacturing pipeline, our crewing can handle these on short notice, provided we have the heads up. This flexibility isn’t just a marketing pitch—it’s day-to-day reality on our shop floor.
In the past five years, global scrutiny of aroma and intermediate chemicals has tightened, with many countries rolling out tighter import documentation, VOC regulations, and mandatory traceability logs. Dehydrocamphonine production found itself swept up in the paperwork alongside all terpenoids.
Our internal compliance team spends significant effort not only meeting these new standards but anticipating upcoming ones. Having full batch histories and chained custody documents is non-negotiable now, and as a manufacturer, we’ve baked that mindset into not only operations but also the technical training our crew receives.
We track regulatory changes across the main importing and using jurisdictions—Europe, the United States, and parts of Asia. Several years ago, a client flagged a compound closely related to Dehydrocamphonine after it drew scrutiny from a regional authority over purity thresholds. By pre-empting adjustments in our own product, we avoided export delays and kept material flowing to the labs that depended on us.
Over multiple years and hundreds of batches, the team has refined testing protocols for each shipment. GC-MS profiles track not only purity but highlight trace byproducts at the low parts-per-million level. Thanks to this, we’ve been able to guarantee tight specification every time. Laboratories who purchase from us routinely comment on the lack of chromatographic “ghosts” or unexpected peaks that can otherwise dog reference runs in analytical development.
Only trained chemists sign off on batch releases. This approach, requiring the human touch over automated checkboxes, allows early catches of rare deviations. A case from last year—when a subtle exotherm went unnoticed until final filtration—reminded us that machines can flag numbers, but trained experience recognizes patterns. The resulting catch prevented a low-grade shipment from leaving the dock, reinforcing our preference for skill-backed oversight.
Though Dehydrocamphonine currently maintains its position as a secondary ingredient in aroma chemistry and fine synthesis, interest continues to rise in niche fields. Our inquiries now split between traditional fragrance and pharmaceutical development—teams looking for adaptable intermediates with well-understood supply chains.
Challenges arise as end-user specifications narrow and regulatory frameworks tighten. The diversity of applications brings varied purity demands, solvent residue limits, and batch-size preferences. Rather than seeing this as a complication, we treat it as a regular part of evolving with our partners. Ongoing investment in both equipment and in skilled team members remains the only path forward. We’ve resisted outsourcing critical steps and continue to favor vertical integration, keeping raw material qualification, reaction, purification, and packaging in-house.
Going forward, digital batch tracking and additional in-process triggers for deviation flagging stand as top items on our roadmap. These technologies should reduce reaction time to issues and add further confidence for regulatory or customer audits. With each new challenge, the lesson remains simple: the manufacturer’s experience and hands-on knowledge shape the final product in ways that paperwork and marketing never could.
Over years of handling Dehydrocamphonine, we’ve built up a position reflecting both reliability and commitment, not only to product but to each customer’s application. It means vetting every input, scrutinizing each processing step, and holding our output up to higher standards than our own contracts demand. Customers—whether in fragrance composition, pharmaceuticals, or advanced synthesis—deserve uninterrupted supply matching their expectations. That trust comes from direct experience and accountability for each batch, every time.